High Throughput Screening Assays to Map Macrocyclic Peptide Permeability and Stability Properties
Vanderbilt University
AstraZeneca is seeking high throughput screening assays to map macrocyclic peptide permeability and stability for oral drug development
Reference No.
RFP-2025-3128
Category
Research/Development
Due Date
March 6th, 2026
Description
AstraZeneca is seeking screening assays or predictive models relevant to oral bioavailability and cell permeability of macrocyclic peptides to help map and model the property space required for oral and cell-permeable macrocyclic therapeutics.
Key Requirements
RFP Submission Requirements for Vanderbilt Peptide Assays
Contact Information
What you’ll get when you unlock
All the details after a short form. No spam
- Latest RFP PDF
- Buyer contact sheet
- Submission checklist
- Any addenda links